ஒன்று ஆய்வகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒன்று ஆய்வகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒன்று ஆய்வகம் Today - Breaking & Trending Today

Alicante promueve la gobernanza con el desarrollo digital de la Administración

Alicante promueve la gobernanza con el desarrollo digital de la Administración
informacion.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from informacion.es Daily Mail and Mail on Sunday newspapers.

Academy To , Program To Dynamic , Laboratory To Insights , Agency Local To Development , Territories Future , For Her , Artificial Intelligence , Before Body Parts , Agency Local , Done Lab , க்கு அவள் , செயற்கை உளவுத்துறை , ஒன்று ஆய்வகம் ,

Core One Labs Inc.: Core One Labs Highlights Key Points from International Investor Call


Core One Labs Inc.: Core One Labs Highlights Key Points from International Investor Call
Core One the
Company ) is pleased with the tremendous turnout on the International Investors Call held earlier today. Core One s Chairman, Dr. Robert E.W. Hancock and Chief Executive Officer, Joel Shacker provided participants an update on the Company s current Intellectual Property and patent application process, cost to produce psilocybin, and the commercial viability.
Highlights
Intellectual Property and Patent Process
Dr. Hancock announced that the Company has assembled the necessary data for its research and development program on biosynthetic psilocybin production systems in order to commence the process of preparing and filing its first patent application with the United States Patent and Trademark Office. The initial filing is the first in a series of upcoming patent filings aimed at protecting valuable intellectual property that underpins the proprietary fermen ....

United States , British Columbia , Robertew Hancock , Joel Shacker , Core One Lab , Core One The Company , International Investor Call , Trademark Office , Core One Labs Inc , Drug Administration Good Manufacturing Practice , Canadian Securities Exchange , Health Canada , Core One Labs , Chief Executive Officer , Intellectual Property , United States Patent , Done Lab , Drug Administration , Good Manufacturing Practice , Core One , One Labs , Disclaimer Statement , Controlled Drugs , Substances Act , ஒன்றுபட்டது மாநிலங்களில் , பிரிட்டிஷ் கொலம்பியா ,

Core One Labs Highlights Key Points from International Investor Call


Press release content from Accesswire. The AP news staff was not involved in its creation.
Core One Labs Highlights Key Points from International Investor Call
February 11, 2021 GMT
VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (“Core One” the “Company”) is pleased with the tremendous turnout on the International Investors’ Call held earlier today. Core One’s Chairman, Dr. Robert E.W. Hancock and Chief Executive Officer, Joel Shacker provided participants an update on the Company’s current Intellectual Property and patent application process, cost to produce psilocybin, and the commercial viability. ....

United States , British Columbia , Robertew Hancock , Joel Shacker , Core One Lab , Core One The Company , International Investor Call , Trademark Office , Core One Labs Inc , Drug Administration Good Manufacturing Practice , Canadian Securities Exchange , Health Canada , Core One Labs , Chief Executive Officer , Intellectual Property , United States Patent , Done Lab , Drug Administration , Good Manufacturing Practice , Core One , One Labs , Disclaimer Statement , Controlled Drugs , Substances Act , Corporate News , North America ,